Daniel Brattström
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 10%
- Surgery
- Co-authors
- Gunnar WageniusMichael BergqvistPatrik HesseliusOla BrodinMaureen TrudeauRoger HenrikssonJustin P.O. LindemannJonas Bergh
- Topics
- Lung Cancer Treatments and Mutations (8 papers)Esophageal Cancer Research and Treatment (7 papers)Angiogenesis and VEGF in Cancer (7 papers)
- Partner nations
- SwedenUnited KingdomCanada
In The Last Decade
Daniel Brattström
43 papers receiving 848 citations
Peers
Comparison fields: 5 of 74
- Oncology 451
- Pulmonary and Respiratory Medicine 401
- Molecular Biology 365
- Cancer Research 237
- Surgery 130
Countries citing papers authored by Daniel Brattström
This map shows the geographic impact of Daniel Brattström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Brattström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Brattström more than expected).
Fields of papers citing papers by Daniel Brattström
This network shows the impact of papers produced by Daniel Brattström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Brattström. The network helps show where Daniel Brattström may publish in the future.
Co-authorship network of co-authors of Daniel Brattström
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Brattström. A scholar is included among the top collaborators of Daniel Brattström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Brattström. Daniel Brattström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 17 | |
| 3 | The role of circulating angiogenic factors in patients operated on for localized malignant melanoma. | 8 |
| 4 | 45 | |
| 5 | 52 | |
| 6 | Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment. | 8 |
| 7 | 11 | |
| 8 | 6 | |
| 9 | 15 | |
| 10 | 17 | |
| 11 | 32 | |
| 12 | 15 | |
| 13 | 39 | |
| 14 | 12 | |
| 15 | 55 | |
| 16 | Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma. | 16 |
| 17 | 22 | |
| 18 | 18 | |
| 19 | 12 | |
| 20 | Basic fibroblast growth factor and vascular fibroblast growth factor measured in sera from patients with non-small cell lung cancer. | 3 |
About Daniel Brattström
Daniel Brattström is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 43 papers that have together received 874 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Esophageal Cancer Research and Treatment (7 papers) and Angiogenesis and VEGF in Cancer (7 papers). The work is most often cited by research in Oncology (451 citations), Cancer Research (237 citations) and Pulmonary and Respiratory Medicine (401 citations). Daniel Brattström has collaborated with scholars based in Sweden, United Kingdom and Canada. Frequent co-authors include Gunnar Wagenius, Michael Bergqvist, Patrik Hesselius, Ola Brodin, Maureen Trudeau, Roger Henriksson, Justin P.O. Lindemann, Jonas Bergh, W. Eiermann and Elisabet Lidbrink. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.